IQVIA Holdings, US46266C1053

IQVIA Holdings stock holds near its yearly high

Published on 09/06/2026 at 12:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IQVIA Holdings stock stays close to its 52-week peak after July 28, 2026 earnings of USD 3.15 a share and revenue of USD 4.37 billion.

Modernes Pharmaforschungslabor mit Wissenschaftlern an Datenanalysesystemen
IQVIA Holdings betreibt ein modernes Pharmaforschungslabor US46266C1053 mit Wissenschaftlern an klinischen Datenanalysesystemen, Illustration mit AI erstellt.

IQVIA Holdings stock (ISIN US46266C1053) closed near its 52-week high as of September 5, 2026, with a price of USD 267.77, market capitalization of USD 44.06 billion and a 52-week range from USD 154.50 to USD 271.80. The latest quarter on July 28, 2026 also gave the market fresh numbers: adjusted EPS was USD 3.15, above the USD 3.03 consensus, and revenue reached USD 4.37 billion, up 8.7 percent year over year.

July quarter still sets the tone

MarketBeat reported on September 5, 2026 that the July 28, 2026 quarter remained the main reference point for IQVIA after the company posted USD 3.15 in adjusted EPS and USD 4.37 billion in revenue. The same report said IQVIA kept FY 2026 guidance at USD 12.80 to USD 13.00 in EPS, while sell-side analysts were looking for USD 11.57 for the full year.

That spread matters for valuation. The quarter combined an EPS beat of USD 0.12 with revenue that was USD 70 million above consensus, and the stock still traded only USD 4.03 below its 52-week high of USD 271.80 on September 5, 2026.

Analysts and insiders

According to a September 6, 2026 MarketBeat filing, Raiffeisen Bank International sold 5,777 shares, cutting its position to 6,500 shares. The same source also described a consensus rating of Moderate Buy and a consensus target price of USD 243.62.

The insider backdrop was mixed as well. A September 2, 2026 sale by James Berkshire totaled 2,668 shares at an average price of USD 261.33, while institutional investors were reported at 89.62 percent of the stock and insiders at 1.70 percent.

IQVIA business mix

IQVIA's core story still runs through its contracted research and data platform, where quarterly execution is measured by revenue growth, margin and guidance. The July 28, 2026 quarter showed a net margin of 8.10 percent and return on equity of 30.25 percent, which gives the stock a profitability base that investors tend to watch closely when the shares trade near a yearly high.

Stock level on September 5

As of September 5, 2026, IQVIA stock traded at USD 267.77, with intraday movement between USD 262.60 and USD 271.80 and volume of 1.15 million shares. The session ended just below the 52-week high, so the next market test is whether the stock can keep price and earnings momentum aligned.

Company data

  • Company: IQVIA Holdings Inc.
  • ISIN: US46266C1053
  • Ticker: IQV
  • Trading venue: NYSE
  • Price (as of September 5, 2026, 4:05 PM): USD 267.77
  • Market capitalization: USD 44.06 billion (as of September 5, 2026)
  • Sector / Industry: Health Care / Life Sciences Tools and Services
  • Index membership: Russell 1000

More on IQVIA stock

Disclaimer...

en | US46266C1053 | IQVIA HOLDINGS | boerse | 70059612 | bgmi